Key Takeaways from the CDDF Webinar on Development of Novel and Targeted Agents in Precision Cancer Prevention and Interception
Take a look at the key takeaways from the recent CDDF Webinar on Development of Novel and Targeted Agents in Precision Cancer Prevention and Interception which took place on 15 June 2023: 1️⃣ Advancements in preclinical biomarker identification and genetic profiling...
Summary Report: Involving and Engaging People with Cancer in Oncology Drug Development
The CDDF is delighted to announce that the summary report, Involving and Engaging People with Cancer in Oncology Drug Development, has been published today. This report is prepared by Professor Mark Lawler (Queen’s University Belfast & Board of the CDDF) and...
Multi-Stakeholder Interviews: CDDF Workshop on Dose Optimization in Early Oncology Drug Development (3-4 April 2023, NL)
[WATCH THE CDDF’S INTERVIEWS WITH MULTI-STAKEHOLDERS IN ONCOLOGY] The CDDF multi-stakeholder workshop on Dose Optimization in Early Oncology Drug Development (3-4 April 2023, Amsterdam) generated lots of interest and fruitful discussion among meeting attendees from...
[New Publication]: Meeting Report of the Annual Conference 2023
📢 The Cancer Drug Development Forum (CDDF) is happy to inform all stakeholders that its meeting report of the Annual Conference 2023 has been published. The 2023 edition of the multi-stakeholder conference took place on 6-8 February 2023 in Noordwijk aan zee, NL. It...
Executive Summary of the Workshop on “Dose Optimization in Early Oncology Drug Development” (April 2023, Amsterdam)
The Cancer Drug Development Forum (CDDF) has published its executive summary of the workshop on “Dose Optimization in Early Oncology Drug Development.” The multi-stakeholder workshop took place on 3-4 April 2023 in Amsterdam, NL. The gathering brought together the...
Join the CDDF Office Team – Event Coordinator
[CDDF Office: Job vacancy - Event Coordinator] The CDDF is seeking an event coordinator to assist with the organization and delivery of programmes and events, ranging from small workshops and a yearly conference to webinars. Join the CDDF team and work together with...
KEY TAKEAWAYS FROM THE CDDF WEBINAR – REGULATORY CONSIDERATIONS FOR IMMUNOTHERAPY & RADIOTHERAPY COMBINATIONS
[READ KEY TAKEAWAYS FROM THE CDDF WEBINAR] The Cancer Drug Development Forum (CDDF) held a live webinar on the topic of regulatory considerations for Immunotherapy and Radiotherapy Combinations on Monday 27 February 2023. Here are the key takeaways from Prof Paz...
Interviews with the CDDF’s Key Stakeholders
The Cancer Drug Development Forum (CDDF) greatly values all stakeholders’ voices and engagement which help the oncology community break down silos and continue open, meaningful dialogue. To accelerate oncology drug development and deliver optimal treatment to cancer...
CDDF Annual Conference 2023: Executive Summary
📢 The Cancer Drug Development Forum (CDDF) is delighted to inform you that its executive summary of the Annual Conference 2023 has been published and is available to all our stakeholders. The 2023 edition of the multi-stakeholder conference took place on 6-8 February...



![[New Publication]: Meeting Report of the Annual Conference 2023](https://cddf.org/wp-content/uploads/2023/04/EXECUTIVE-SUMMARY-1-400x250.jpg)




